J. Russel Denton - 15 May 2026 Form 4 Insider Report for Caris Life Sciences, Inc. (CAI)

Reporting relationship: Senior Vice President, General Counsel, and Secretary
Issuer ticker: CAI
Reported as of: 15 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 May 2026, 16:23:48 UTC
Prior SEC filing: 10 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ J. Russel Denton

Key filing fact

J. Russel Denton filed Form 4 for Caris Life Sciences, Inc. (CAI) on 18 May 2026.

Key facts

This page summarizes J. Russel Denton's Form 4 filing for Caris Life Sciences, Inc. (CAI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 18 May 2026, 16:23.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

CIK 0002071923 Primary reporting owner

Relationship: Senior Vice President, General Counsel, and Secretary
Address: C/O CARIS LIFE SCIENCES, INC., 750 W. JOHN CARPENTER FREEWAY, SUITE 800, IRVING
Signature: /s/ J. Russel Denton
Signature date: 18 May 2026

Shares, units, or other non-derivative securities reported in this filing.

CAI transaction

Tax liability

CAI holding

No transaction description listed

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 1 footnote

Footnote F1

Shares withheld for the payment of taxes on the vesting and settlement of RSUs.

SEC remarks

Senior Vice President, General Counsel, and Secretary